Back to TopIntroduction
This information will help you understand your choices, whether you
share in the decision-making process or rely on your doctor's
recommendation.
Key points in making your decision
For most men faced with
testicular cancer, surgery to remove the affected
testicle (radical inguinal orchiectomy) is the first treatment. After you have
completed this step, you and your health professional will discuss your options
for further treatment.
If you are diagnosed with
seminoma testicular cancer and testing suggests that
it has not spread beyond the testicles (testes), you
might have choices. Your options may include a
watchful waiting program, or
radiation therapy or
chemotherapy to kill any stray cancer cells. (For this
type of cancer, chemotherapy is a newer treatment.1
It is mostly used in Europe.) Consider the following when making your
decision:
- These treatment options lead to about the same long-term
survival in men with stage I seminoma. So your choice can be driven by what you
think about the side effects and long-term effects of each.
- If your
biggest concern is that testicular cancer might come back elsewhere in your
body (metastasize), consider radiation therapy. This treatment is the best
option for completely wiping out this kind of cancer.
- Treatments
do have risks. Radiation can cause
infertility and raises the risks of getting other
cancers later in life. Chemotherapy can make you sick while you take it, and
may also cause infertility. Watchful waiting allows you to avoid these risks,
at least for now, but it could allow cancer to come back.
- You could be one of the 1 in 4 men (about 25%) who get cancer
again after a period of watchful waiting.2 If so, you
may need to have more aggressive treatment than if you have radiation or
chemotherapy right after your orchiectomy.
- You can consider
watchful waiting if you are willing to follow a schedule of regular checkups
and
CT scans. If cancer comes back, it is important to
treat it in its early stage.
- If you want to avoid the intense
follow-up required for watchful waiting but you are worried that radiation or
chemotherapy might harm your fertility, ask your doctor about sperm banking
before treatment.
For information about treatment options for stage I nonseminoma
testicular cancer, see:
Which treatment should I have for stage I
nonseminoma testicular cancer?
Back to TopMedical Information
What is stage I seminoma testicular cancer?
Testicular cancer is a disease involving the uncontrolled growth
of cells on or inside the testicles, or testes.
There are two main types of testicular cancer: seminoma and
nonseminoma germ-cell tumors (or NSGCTs). Unlike NSGCTs, seminoma cells die off
when treated with radiation therapy.2 Seminomas are
also less likely to spread (metastasize) to the lungs, liver, and brain.
Stage I testicular cancers are those that are believed to be
confined to the testes. In some cases, they may have spread to the
lymph nodes of the lower back (retroperitoneum) but
are undetectable.
Unlike many other kinds of cancer, most testicular cancers are
slow-growing and respond well to common treatments (adjuvant therapies) such as
chemotherapy and
radiation therapy. However, adjuvant therapies may
cause both short- and long-term side effects.
What are the treatment options for stage I seminomas?
Following orchiectomy, some stage I seminomas may be treated with
radiation therapy, chemotherapy, or watchful waiting. (Chemotherapy for stage I
seminoma is used mainly in Europe. But this type of medicine is available in
the United States.)
- Radiation therapy.
Radiation is a common treatment for seminomas at all stages of the disease.
Because the lymph nodes in the pelvis and lower back are the most common areas
of metastasis for testicular cancers, radiation is often focused on that area.
During the early phases of stage I seminoma testicular cancer, it can be very
difficult to tell whether these lymph nodes are cancerous, which is why
radiation may be used even when no cancer can be seen. Although it is uncommon,
radiation therapy can cause long-term health conditions including infertility
and an increased chance of developing cancer later in life.
- Chemotherapy. Chemotherapy is the use of
very powerful medicine that kills cancer cells.
Carboplatin is considered a good choice for stage I
seminoma. This is because its side effects are not as bad as some chemotherapy
drugs, and it works well.1
- Watchful waiting. This means you are being monitored closely
by your doctor but are not receiving active treatment. You have a minimum of
one CT scan every 3 months for 2 years following orchiectomy, along with
frequent physical exams and blood tests. Assuming no recurrent cancer is found,
the number of CT scans needed will gradually drop to about one per year after 4
to 7 years and should be unnecessary after 10 cancer-free years. This follow-up
work can be difficult for some men to do. About 25% of men (1 out of 4) who
choose watchful waiting for stage I seminomas develop cancer within 3 to 4
years and require additional treatment.3
In some cases of stage I disease, it has been shown that other
treatment following surgery (adjuvant therapy) is unnecessary following
orchiectomy because the cancer has not spread beyond the testes. In addition,
even when cancer is discovered after a period of watchful waiting, it is often
easily cured provided the follow-up schedule has been followed closely. Because
of this, many health professionals consider watchful waiting a legitimate
treatment option for some men with stage I testicular cancers.
What are the risks of radiation therapy?
Radiation therapy for testicular cancer has side effects. Most
are short-term and do not pose any serious health threat. Other side effects,
although uncommon, can permanently affect your lifestyle and future health. The
most serious long-term risks associated with radiation therapy for testicular
cancer include:
- Infertility. Radiation
may cause permanent infertility in some men. Because many men diagnosed with
testicular cancer are younger than 35, fertility issues are often important in
making treatment decisions. Although most radiation treatment programs do not
permanently affect healthy sperm counts, many health professionals recommend
sperm banking before orchiectomy for those men who may wish to have children in
the future.
- Secondary cancer. Cancers
resulting from radiation therapy may include leukemia, as well as cancers of
the colon, bladder, kidneys, and prostate. Radiation therapy, although focused
on cancer cells, also exposes many of the body's healthy cells to harmful
radiation. Because many men who undergo successful treatment for testicular
cancer go on to live for decades, damage to the body's healthy cells caused by
radiation may not become apparent until many years after treatment is
completed.
What are the risks of chemotherapy?
Chemotherapy affects rapidly growing cells in your body. Besides
cancer cells, this includes blood cells, hair cells, and the cells that line
your digestive tract. Common short-term side effects include nausea and
vomiting, hair thinning or hair loss, mouth sores, diarrhea, and an increased
chance of bleeding and infection. Many men do not have problems with these side
effects. Other men have a great deal of difficulty. If you have problems, your
health professional can use other medicines to help relieve some of these side
effects.
Side effects of carboplatin include:
- Decreased white blood counts. Red blood cell
counts and platelet counts can also be reduced.
- Nausea, vomiting,
and loss of appetite.
- Diarrhea or
constipation.
- Numbness and tingling in the hands or feet
(peripheral neuropathy).
- Hearing changes or hearing
loss.
- Mild rash.
- Hair loss. This is reversible, and
hair will grow back when treatment ends.
- Mouth sores
(stomatitis).
- Changes in kidney and liver function tests.
You may not be able to father children after taking carboplatin.
Discuss fertility with your doctor before starting treatment.
Carboplatin can cause birth defects. Do not use this medicine if
you wish to father a child while you are taking it.
Do not use this medicine if you have:
What are the risks of watchful waiting?
Perhaps the greatest risk of choosing watchful waiting for
testicular cancer has to do with missing your follow-up tests and exams.
Without regular testing and check-ups, you can miss recurrent cancer until it
spreads beyond the lymph nodes and is more difficult to cure.
If you choose watchful waiting, it is very important to strictly
follow your doctor's schedule of tests and exams.
About 25% of men (1 out of 4) who choose watchful waiting
instead of radiation therapy following orchiectomy will have their cancer
return.3 In most cases, the recurrent cancer is
confined to lymph nodes in the lower back and pelvis and can be successfully
treated if the follow-up schedule has been closely followed and the cancer is
discovered when it first appears. However, cancer that reappears during
watchful waiting may require treatment with more aggressive therapy (including
chemotherapy or radiation) than if radiation therapy had been chosen
immediately following orchiectomy.
Watchful waiting is a reasonable choice for many men with stage I
seminoma testicular cancer. However, a successful watchful waiting program
depends upon diligent follow-up care by you and your health
professional.
Back to TopYour Information
Your choices are:
- Try watchful waiting.
- Have
radiation therapy.
- Have chemotherapy.
The decision about whether to choose watchful waiting, radiation
therapy, or chemotherapy takes into account your personal feelings and the
medical facts.
Deciding about watchful
waiting| Reasons to choose watchful waiting | Reasons not to choose watchful
waiting |
|---|
- Orchiectomy alone cures testicular cancer
in about 25% of men (1 out of 4)with stage I seminoma.3
- You avoid the possible side effects related to
radiation therapy or chemotherapy.
Are there other reasons you might want to choose watchful
waiting? | - If cancer returns, you may need more
aggressive treatment than you would have needed if you had had treatment right
after orchiectomy.
- Watchful waiting involves a strict schedule of many
appointments and tests that you may find difficult to
follow.
- Watchful waiting can be very stressful for people
(patients, family, and friends) who are waiting to see if the cancer
returns.
Are there other reasons you might not want to choose watchful
waiting? |
Deciding about radiation
therapy| Reasons to choose radiation therapy | Reasons not to choose radiation
therapy |
|---|
- Radiation therapy following orchiectomy
cures stage I seminoma in 98% of men.3, 4
- The follow-up schedule is much shorter than with
watchful waiting.
Are there other reasons you might want to choose radiation
therapy? | - Long-term side effects are uncommon but
may include
infertility and an increased chance of developing
cancer later in life.
Are there other reasons you might not want to choose
radiation therapy? |
Deciding about chemotherapy| Reasons to choose chemotherapy | Reasons not to choose chemotherapy |
|---|
- For stage I seminomas, chemotherapy with
carboplatin is as effective as radiation (4 years after treatment).1
Are there other reasons you might want to choose
chemotherapy? | - You do not have a doctor who offers
chemotherapy for stage I seminoma.
- Carboplatin can cause
infertility.
- If you father a child while you are taking
carboplatin, your baby has a higher chance of having birth defects.
Are there other reasons you might not want to choose
chemotherapy? |
These
personal stories may help you make your
decision.
Back to TopWise Health Decision
Use this worksheet to help you make your decision. After
completing it, you should have a better idea of how you feel about choosing
among watchful waiting, chemotherapy, and radiation therapy. Discuss the
worksheet with your doctor.
Circle the answer that best applies to you.
I am willing to risk having future health problems if it
means that my testicular cancer will be cured for good. | Yes | No | Unsure |
Radiation therapy or chemotherapy will fit into my busy
life, and I can continue to work without needing to take a lot of time off for
doctor visits and tests. | Yes | No | Unsure |
I am concerned that if I have radiation therapy or
chemotherapy, I may never be able to have children. | Yes | No | Unsure |
I would like to avoid increasing my chance of developing
another type of cancer later in life. | Yes | No | Unsure |
I am concerned that I won't be able to stick to my doctor's
follow-up schedule if I choose watchful waiting. | Yes | No | Unsure |
I am willing to put up with the stress of a watchful
waiting program if it means I might not need radiation or chemotherapy to cure
my cancer. | Yes | No | Unsure |
Use the following space to list any other important concerns you
have about this decision.
What is your overall impression?
Your answers in the above worksheet are meant to give you a
general idea of where you stand on this decision. You may have one overriding
reason to choose watchful waiting, chemotherapy, or radiation therapy.
Check the box below that represents your overall impression about
your decision.
Leaning toward watchful
waiting | | Leaning toward treatment |
Leaning toward
chemotherapy | | Leaning toward radiation
therapy |
Return to the topic
Testicular Cancer.
Back to TopReferences
Citations
Oliver RTD, et al. (2005). Radiotherapy versus
single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomized
trial. Lancet, 366: 293–300.
Raghavan D (2003). Bladder, renal, and testicular
cancer. In DC Dale, DD Federman, eds., Scientific American
Medicine, vol. 3, part 12, chap. 14. New York: WebMD.
Vuky J, Motzer RJ (2003). Testicular germ cell cancer.
In B Furie et al., eds., Clinical Hematology and
Oncology, pp. 813–824. Philadelphia: Churchill Livingstone.
Small EJ, Torti FM (2002). Testis. In M Dollinger et
al., eds., Everyone's Guide to Cancer Therapy, 4th ed.,
pp. 770–780. Kansas City: Andrews McMeel.
Oliver RTD, et al. (2005). Radiotherapy versus
single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomized
trial. Lancet, 366: 293–300.
Raghavan D (2003). Bladder, renal, and testicular
cancer. In DC Dale, DD Federman, eds., Scientific American
Medicine, vol. 3, part 12, chap. 14. New York: WebMD.
Vuky J, Motzer RJ (2003). Testicular germ cell cancer.
In B Furie et al., eds., Clinical Hematology and
Oncology, pp. 813–824. Philadelphia: Churchill Livingstone.
Small EJ, Torti FM (2002). Testis. In M Dollinger et
al., eds., Everyone's Guide to Cancer Therapy, 4th ed.,
pp. 770–780. Kansas City: Andrews McMeel.